mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.1 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.1 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |